中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 1
Jan.  2018
Turn off MathJax
Article Contents

Effect of TNF-like weak inducer of apoptosis and its receptor on migration of hepatic stellate cells

DOI: 10.3969/j.issn.1001-5256.2018.01.024
Research funding:

 

  • Published Date: 2018-01-20
  • Objective To investigate the effect of TNF-like weak inducer of apoptosis ( TWAEK) and its receptor fibroblast growth factor-inducible 14 ( Fn14) on the migration of hepatic stellate cells and the possible mechanism. Methods The human hepatic stellate cell line LX-2 cells were treated with TWEAK or Fn14 specific small interfering RNA ( Fn14 siRNA) + TWEAK. Transwell chamber was used to observe the migration of hepatic stellate cells, and real-time PCR and Western blot were used to measure the expression of matrix metalloproteinase-9 ( MMP9) . The independent samples t-test was used for comparison of continuous data between two groups; a one-way analysis of variance was used for comparison between multiple groups, and the least significant difference t-test was used for further comparison between two groups. Results Compared with normal LX-2 cells, the TWEAK group had a significant increase in the migration of LX-2 cells ( 105 ± 8 vs 164 ± 17, t = 5. 287, P < 0. 01) , and compared with the negative control group, the Fn14 siRNA + TWEAK group had a significant reduction in the number of migrated cells ( 122 ± 9 vs 58 ± 7, t = 9. 836, P < 0. 01) . When LX-2 cells were treated with TWEAK, the mRNA and protein expression of MMP9 increased in a time-dependent manner ( both P < 0. 05) , while the Fn14 siRNA +TWEAK group had significant reductions in the mRNA and protein expression of MMP9 compared with the TWEAK group ( t = 5. 358, P <0. 01) . Conclusion TWEAK and its receptor Fn14 can promote the migration of hepatic stellate cells by upregulating MMP9, and blockade of this pathway may become a potential target for the treatment of liver fibrosis.

     

  • loading
  • [1]HIGASHI T, FRIEDMAN SL, HOSHIDA Y.Hepatic stellate cells as key target in liver fibrosis[J].Adv Drug Deliv Rev, 2017.[Epub ahead of print]
    [2]KISSELEVA T.The origin of fibrogenic myofibroblasts in fibrotic liver[J].Hepatology, 2017, 65 (3) :1039-1043.
    [3] TSUCHIDA T, FRIEDMAN SL.Mechanisms of hepatic stellate cell activation[J].Nat Rev Gastroenterol Hepatol, 2017, 14 (7) :397-411.
    [4]HUANG JX, ZHU BH, HE D, et al.Curcumine inhibits migration and invasion of hepatic stellate cells by reducing MMP-2 expression and activity[J].Chin J Hepatol, 2009, 17 (11) :835-838. (in Chinese) 黄建贤, 朱宝和, 贺德, 等.姜黄素抑制HSC-T6细胞迁徙和侵袭的机制[J].中华肝胆病杂志, 2009, 17 (11) :835-838.
    [5]CHANG YZ, YANG L, YANG CQ.Migration of hepatic stellate cells in fibrotic microenvironment of diseased liver model[J].Hepatobiliary Pancreat Dis Int, 2008, 7 (4) :401-405.
    [6]TIRNITZ-PARKER JE, VIEBAHN CS, JAKUBOWSKI A, et al.Tumor necrosis factor-like weak inducer of apoptosis is a mitogen for liver progenitor cells[J].Hepatology, 2010, 52 (1) :291-302.
    [7]PORTILLA D.Apoptosis, fibrosis and senescence[J].Nephron Clin Pract, 2014, 127 (1-4) :65-69.
    [8]CHICHEPORTICHE Y, BOURDON PR, XU H, et al.TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis[J].J Biol Chem, 1997, 272:32401-32410.
    [9]WILEY SR, CASSIANO L, LOFTON T, et al.A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis[J].Immunity, 2001, 15 (5) :837-846.
    [10]WILEY SR, WINKLES JA.TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14receptor[J].Cytokine Growth Factor Rev, 2003, 14 (3-4) :241-249.
    [11]BURKLY LC, MICHAELSON JS, ZHENG TS.TWEAK/Fn14pathway:an immunological switch for shaping tissue responses[J].Immunol Rev, 2011, 244 (1) :99-114.
    [12]PATSENKER E, POPOV Y, WIESNER M, et al.Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB induced hepaticstellate cell migration and activation in vitro[J].J Hepatol, 2007, 46 (5) :878-887.
    [13]GE HY, ZHANG SH.Research advances in association between matrix metalloproteinases and liver fibrosis[J].J Clin Hepatol, 2017, 33 (3) :563-566. (in Chinese) 戈宏焱, 张仕华.基质金属蛋白酶与肝纤维化关系的研究进展[J].临床肝胆病杂志, 2017, 33 (3) :563-566.
    [14]PRYSTUPA A, BOGUSZEWSKA-CZUBARA A, BOJARSKA-JUNAK A, et al.Activity of MMP-2, MMP-8 and MMP-9 in serum as a marker of progression of alcoholic liver disease in people from Lublin Region, eastern Poland[J].Ann Agric Environ Med, 2015, 22 (2) :325-328.
    [15]DUARTE S, BABER J, FUJII T, et al.Matrix metalloproteinases in liver injury, repair and fibrosis[J].Matrix Biol, 2015, 44-46:147-156.
    [16]YANG C, ZEISBERG M, MOSTERMAN B, et al.Liver fibrosis:insights into migration of hepatic stellate cells in response to extracellular matrixand growth fators[J].Gastroenterology, 2003, 124 (1) :147-159.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2202) PDF downloads(440) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return